Investment management company Artisan Partners stated in its Q2 2026 investor letter, released today, that its Artisan Mid Cap Fund exited its position in American medical device company Insulet Corporation (NASDAQ:PODD). The fund cited increasing competition in the insulin pump market, which has reduced visibility into Insulet's medium-term growth and market share outlook, leading it to redeploy capital into higher conviction opportunities.